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INTRODUCTION
The major drawbacks in the treatment of microbial 
infections are microbial resistance and the adverse effects of 
old antibiotics (1). In recent times, the excessive increase in 
microbial resistance, especially among Gram-positive 
bacteria, has increased the need for new compounds that 
have a large antimicrobial effect (2). Therefore, a new class 
of antimicrobial compounds are needed to combat the antimi
crobial resistance. These new agents can be extracted from 
plant sources (3) or synthesized in vitro (4).
    Nitrofurans are chemical compounds that contain the 
5-nitrofuran ring in their molecular structure (5). This group 
acts as a bacteriostatic agent against a wide range of 
Gram-positive and Gram-negative bacteria and has bacteri-
cidal activity at higher doses. They create superoxide and 
toxic oxygen radicals under reducing conditions, which 
oxidize the vital components of the cell and disrupt the 
normal functioning of the bacteria, fungi, and protozoa (5). 
Moreover, nitrofurans are used as pharmacophores to 
achieve more effective compounds, and because of their 
excretion in the urine, these compounds are a good choice 
for the treatment of urinary tract infections (6). Nitroimida-
zoles are imidazole derivatives with a nitro group that are 
effective against anaerobic bacteria and parasitic infections 
such as Trichomonas vaginalis and Entamoeba histolytica 
(7). These reducing agents cause the breakdown of DNA, 
which depends on the A and T content, and also inhibit the 
repairing of the DNA damages (8). In addition, the 1,3,4-thi-
adiazole acts as the cornerstone in the development of 
pharmacological substances. According to previous 
research, this ring has antibacterial antifungal, antihista-
minic, anticholinergic, and anti-inflammatory effects (9). 
    In the present study, the antibacterial effects of the 
1,3,4-thiadiazole ring of the 5-nitrofurazone and 5-nitroimi-
dazole derivatives against eight most common bacterial 
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MATERIALS AND METHODS
species were evaluated. 
    The implementation of modern mathematical techniques 
helps in the selection of important informative indicators 
and in aggregating the information about a worker’s psycho-
physiological state to correctly evaluate the efficiency in 
their professional activity and risks (6). A new technology of 
video survey was developed to determine the quality of 
performance of the occupational duties (7). To analyze the 
most valuable psychological and behavioral characteristics 
of a worker, some authors build factor models that are useful 
in selecting staff (8). The external assessments of the 
workers’ technique proved to be productive for analyzing 
the efficiency of their professional activity and its connec-
tion with psychophysiological characteristics (9). The frame-
work "modular approach" serves to increase the effective-
ness of a worker’s professional suitability evaluation (10). 
This technique is based on splitting the initial data into key 
components; then, the received "modular" information is 
considered separately with respect to the differences 
between the data in the selected subgroups. This approach 
allows to develop some deeper understanding of the role of 
the individual components underlying the selection 
procedure and to show their possible interconnection. Some 
indicators that have an impact on the ability to provide the 
occupational activities are identified based on factor 
analysis. Important psychophysiological factors are 
cognitive abilities, communication and computer skills, 
physical abilities, interpersonal communication skills, 
ability to provide security, independence, ability to adapt to 
the structure of a particular activity, and more specific 
abilities that are related to the problem performance (11). 
However, the key factors that cause stress and pressure on 
the workers of different occupations are different. In the 
electric power engineering industry, information loading is 
too important (12). The determination of disabilities empha-
sizes the importance of psychophysiological selection for 
the prevention of traffic safety but unfortunately do not 
provide any solution to get an occupational risk evaluation 
(13). The quantitative results of such an investigation only 
affirm that the frequency of errors by female operators is 
2.16 times higher than by men. 
    Regardless of some success in the investigation, we 
observed a lack of clear quantitative results concerning the 
risk of loss or depletion in the efficiency of occupational 
duties during the work life. Furthermore, because of the 
incomplete investigation of these issues, there are still no 
approaches for the evaluation of the efficiency in reducing 
the risk factor in occupational psychophysiological 
selection. Thus, we need a methodology to evaluate the risks 
by using a certain number of psychophysiological character-
istics. The aim of our investigation is to develop an approach 
for the quantitative evaluation of the efficiency of risk 
reduction in a worker’s occupational activity, probability of 
health, and safety depletion during the entire life period of 
work. 
-
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Thioglycolate media, dimethyl sulfoxide (DMSO), 
Mueller-Hinton broth (MHB) and Mueller-Hinton agar 
(MHA), nutrient agar, soybean casein digest agar (SCDA) 
and soybean casein digest broth (SCDB), bromine monochlo-
ride (BrCl), and sulfuric acid (H2SO4) were purchased from 
Merck (Germany). All other chemical compounds were of 
analytical grade and were available commercially. Evaluat-
ed bacterial strains included the Gram-positive bacteria 
Staphylococcus epidermidis (PTCC1114), Bacillus subtilis 
(PTCC1023), Sterptococcus pyogenes (PTCC1447), and 
Micrococcus luteus (PTCC1110) and Gram-negative 
bacteria Escherichia coli (PTCC1330), Pseudomonas aerugi-
nosa (PTCC1074), Klebsiella pneumonia (PTCC1053), and 
Serratia marcescens (PTCC1621).
    We synthesized 7 new derivatives of (5-nitro-2-furyl)- and 
(5-nitro-2-imidazolyl)-1,3,4-thiadiazole in the Pharma-
cochemistry lab of Tehran University. The molecular 
weight, formula, chemical name, and chemical structure of 
the synthesized compounds are presented in Table 1 and 
Figure 1, respectively.
C  H  N O S 2-(5-nitro-2-furyl)-5-(n-buthylthio)-1,3,4-thiadiazole
Table 1. Molecular weight, chemical formula, and name of synthesized compounds
Code Molecular weight Chemical formula Chemical name
1 285.34
2-(5-nitro-2-furyl)-5-(n-penthylthio)-1,3,4-thiadiazole2 299.37
2-(5-nitro-2-furyl)-5-(n-pentylsulfinyl)-1,3,4-thiadiazole3 315.37
2-(5-nitro-2-furyl)-5-(n-butylsulfunyl)-1,3,4-thiadiazole4 317.34
2-(5-nitro-2-furyl)-5-(n-pentylsulfunyl)-1,3,4-thiadiazole5 331.37
2-(1-methyl-5-nitro-H1-imidazole-2-yl)-5-(n-butylthio)-
1,3,4-thiadiazole
6 299.37
2-(1-methyl-5-nitro-H1-imidazole-2-yl)-5-(n-pentylsulfinyl)-
1,3,4-thiadiazole
7 329.40
10 11 3 3 2
C  H  N O S11 13 3 3 2
C  H  N O S11 13 3 4 2
C  H  N O S10 11 3 5 2
C  H  N O S11 13 3 5 2
C  H  N O S10 13 5 2 2
C  H  N O S11 15 5 3 2
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3RESULTS
The results of the MIC analysis of the different derivatives 
are presented in Table 2. As demonstrated, the 2-(5-ni-
tro-2-furyl)-5-(n-buthylthio)-1,3,4-thiadiazole showed no 
antibacterial effects against Gram-negative bacteria (MIC > 
64 μg/ml), but completely inhibited the growth of S. epider-
midis and B. subtilis (MIC < 0.5 μg/ml). This derivative had 
a MIC of 8-16 μg/ml against M. luteus and 0.5-1 μg/ml 
against S. pyogenes. The 2-(5-nitro-2-furyl)-5-(n-penthylth-
io)-1,3,4-thiadiazole also showed no antibacterial effects 
against Gram-negative bacteria (MIC > 64 μg/ml), but 
completely inhibited the growth of S. epidermidis, B. 
subtilis, and S. pyogenes (MIC < 0.5 μg/ml). This derivative 
had a MIC of 0.5-1 μg/ml against M. luteus. 
    The 2-(5-nitro-2-furyl)-5-(n-pentylsulfinyl)-1,3,4-thiadi-
azole showed no antibacterial effects against Gram-negative 
bacteria and S. epidermidis (MIC > 64 μg/ml). This deriva-
tive had a MIC of 16-32 μg/ml against M. luteus, B. subtilis, 
and S. pyogenes. The 2-(5-nitro-2-furyl)-5-(n-butylsulfu-
nyl)-1,3,4-thiadiazole also showed no antibacterial effects 
against Gram-negative bacteria and S. epidermidis (MIC > 
64 μg/ml), but this derivative had a MIC of 4-8 μg/ml 
against M. luteus, 16-32 μg/ml against B. subtilis, and 32-64 
μg/ml against S. pyogenes.
    The 2-(5-nitro-2-furyl)-5-(n-pentylsulfunyl)-1,3,4-thiadi-
azole had no antibacterial effects against S. pyogenes, and 
all of the Gram-negative bacteria (MIC > 64 μg/ml), except 
K. pneumonia (MIC of 16-32 μg/ml). This derivative also 
had a MIC of 8-16 μg/ml against M. luteus and B. subtilis, 
and 16-32 μg/ml against S. epidermidis. The 2-(1-me-
t h y l - 5 - n i t r o - H 1 - i m i d a z o l e - 2 - y l ) - 5 - ( n - b u t y l t h -
io)-1,3,4-thiadiazole showed no antibacterial effects against 
Gram-negative bacteria (MIC > 64 μg/ml), but completely 
inhibited the growth of S. epidermidis and B. subtilis (MIC 
< 0.5 μg/ml). The MIC of this derivative was 32-64 μg/ml 
against M. luteus, and 0.5-1 μg/ml against S. pyogenes. 
Finally, the derivative 2-(1-methyl-5-nitro-H1-imida-
zole-2-yl)-5-(n-pentylsulfinyl)-1,3,4-thiadiazole showed no 
Thioglycolate broth (3%) was prepared and autoclaved at 
121°C for 15 min. This media was used for transport of the 
lyophilized bacteria to the 4% SCDA. Also, 3% SCDB was 
prepared in sterile tubes to activate the bacterial strains 
before experiments. Moreover, 2% nutrient agar was used 
for the preparation of batch plates, as a microbial reservoir, 
and for overnight culture, 3.8% MHA for antibacterial 
sensitivity testing, and 2.1% MHB for serial dilution.
     First, 6.4 g of each derivative was added to DMSO, and 
the final volume was made up to 5 ml using distilled water 
to get a 1280 μg/ml solution. Then, eight serial dilutions of 
5, 10, 20, 40, 80, 160, 320, and 640 μg/ml were prepared 
using MHB and MIC (10, 11). Two other tubes with MBH, 
one without samples and the other with a bacterium, as 
negative and positive controls, respectively, were prepared. 
Moreover, two positive and negative control tubes were 
considered for DMSO. All of these dilutions were again 
diluted in the 1:10 using MHB in Petri dish and the final 
dilutions of 0.5, 1, 2, 4, 8, 16, 32, and 64 μg/ml were 
prepared. 
     The 0.5 McFarland standard with a turbidity of 1.5 × 108 
cells/ml was prepared using 0.05 ml of 1.175 w/v BrCl and 
9.95 ml of 1% H2SO4. This standard had 74.3% transmit-
tance and absorbance of 0.08-0.1.
       Lyophilized bacterial species were activated and cultured 
on the MHA, and then, transferred to MHB and incubated at 
30-35°C (depending on the temperature requirement of the 
bacterial species) for 18 h. The turbidity of the bacterial 
suspensions was compared to the 0.5 McFarland standard, 
and if appropriated, 5 μl of each was transferred to MHA and 
incubated at 35-37°C for 18 h. Finally, the minimum inhibito-
ry concentration (MIC) was measured as the minimum 
concentration of each sample which prevented the bacterial 
growth and recorded (12). Ciprofloxacin, as a routine antibi-
otic, was also evaluated. Ciprofloxacin was chosen because 
the first- and second-generation fluoroquinolones like 
ciprofloxacin have an excellent potency against Gram-nega-
tive bacteria and a good activity against the Gram-positive 
bacteria with little corneal toxicity (13, 14).
Figure 1. Chemical structure of the synthesized compounds. Compounds were numbered based on Table 1.
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4Table 2. Growth of different Gram-positive and Gram-negative bacteria in different concentration of the derivatives, 
ciprofloxacin, positive and negative controls
Agents Concentration EC PA SM KP SE ML BS SP
Bacterial ﬆrains
2-(5-nitro-2-furyl)-5-
(n-buthylthio)-1,3,4-thiadiazole
64
32
+ + + + - - - -
+ + + + - - - -
16 + + + + - - - -
8 + + + + - + - -
4 + + + + - + - -
2 + + + + - + - -
1 + + + + - + - -
0.5 + + + + - + - +
2-(5-nitro-2-furyl)-5-
(n-penthylthio)-1,3,4-thiadiazole0
64
32
+ + + + - - - -
+ + + + - - - -
16 + + + + - - - -
8 + + + + - - - -
4 + + + + - - - -
2 + + + + - - - -
1 + + + + - - - -
0.5 + + + + - + - -
2-(5-nitro-2-furyl)-5-
(n-pentylsulfinyl)-1,3,4-thiadiazole
64
32
+ + + + + - - -
+ + + + + - - -
16 + + + + + + + +
+ + + +
+ + + +
+ + + +
+ + + +
+ + + +
8 + + + +
4 + + + +
2 + + + +
1 + + + +
0.5 + + + +
2-(5-nitro-2-furyl)-5-
(n-butylsulfunyl)-1,3,4-thiadiazole
64
32
+ + + + + - - -
+ + + + + - - +
16 + + + + + - + +
+ - + +
+ + + +
+ + + +
+ + + +
+ + + +
8 + + + +
4 + + + +
2 + + + +
1 + + + +
0.5 + + + +
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52-(5-nitro-2-furyl)-5-
(n-pentylsulfunyl)-1,3,4-thiadiazole
64
32
+ + + - - - - +
+ + + - - - - +
16 + + + + + - - +
8 + + + + + + + +
4 + + + + + + + +
2 + + + + + + + +
1 + + + + + + + +
0.5 + + + + + + + +
2-(1-methyl-5-nitro-H1-imidazole-
2-yl)-5-(n-butylthio)-1,3,4-thiadiazole
64
32
+ + + + - - - -
+ + + + - + - -
16 + + + + - + - -
8 + + + + - + - -
4 + + + + - + - -
2 + + + + - + - -
1 + + + + - + - -
0.5 + + + + - + - +
2-(1-methyl-5-nitro-H1-imidazole-
2-yl)-5-(n-pentylsulfinyl)-
1,3,4-thiadiazole
64
32
+ + + + + - - -
+ + + + + + - +
16 + + + + + + - +
+ + - +
+ + - +
+ + + +
+ + + +
+ + + +
8 + + + +
4 + + + +
2 + + + +
1 + + + +
0.5 + + + +
Ciprofloxacin 64
32
- - - - - - + -
- - - - - - + -
16 - - - - - - + -
- + + -
- + + -
- + + -
+ + + -
+ + + +
8 - - - -
4 - - - -
2 - - - -
1 + - - -
0.5 + + - -
+ + + +0.25 + + - -
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6Abbreviations:
SE, Staphylococcus epidermidis (PTCC1114); BS, Bacillus subtilis (PTCC1023); SP, Streptococcus pyogenes (PTCC1447); ML, 
Micrococcus luteus (PTCC1110); EC,  Escherichia coli (PTCC1330); PA, Pseudomonas aeruginosa (PTCC1074); KP, Klebsiella 
pneumonia (PTCC1053); SM, Serratia marcescens (PTCC1621); PC, positive control; NC, negative control.
Controls
PC
NC
DMSO PC
DMSO NC
- - - -
+ + + +
- - - -
- - - -- - - -
+ + + +
+ + + ++ + + +
antibacterial effects against Gram-negative bacteria and S. 
epidermidis (MIC > 64 μg/ml), but had a MIC of 32-64 μ
g/ml against M. luteus, 2-4 μg/ml against B. subtilis, and 
32-64 μg/ml against S. pyogenes.
    Ciprofloxacin as a routine antibiotic was also evaluated, 
and all the microorganisms except B. subtilis were sensitive 
to it. The MIC of ciprofloxacin was 1-2 μg/ml, 0.05-1 μg/ml, 
0.5-1 μg/ml, < 0.25 μg/ml, <0.25 μg/ml, 1-2 μg/ml, and 8-16 
μg/ml against E. coli, P. aeruginosa, S. pyogenes, K. pneumo-
nia, S. marcescens, S. epidermidis, and M. luteus, respective-
ly. 
In the present study, the antibacterial effects of the newly 
synthesized derivatives of (5-nitro-2-furyl) and 
(5-nitro-2-imidazolyl)-1,3,4-thiadiazole against some impor-
tant Gram-positive and Gram-negative bacterial strains were 
evaluated. A wide range of derivatives were prepared using 
an effective anti-Gram-positive and negative nitrofuran ring 
and a nitroimidazole group, which has anti-anaerobic and 
anti-parasitic function, and added to the 1,3,4 thiadiazole 
core. However, our synthesized compounds had lower 
antibacterial activities compared to ciprofloxacin. All the 
bacteria were grown in the presence of these compounds, 
and only mild antibacterial effects against Gram-positive 
bacteria were detected. 
   After comparing the antibacterial effects of the compounds 
based on their chemical structure, we found that the carbon 
chain elongation had no effects on the Gram-negative 
bacterial strains. Moreover, the conversion of the thio-group 
to sulfinyl-group decreased the antibacterial effects against 
S. epidermidis. In addition, increase in the length of the 
hydrocarbon chain from 4 to 5 and the conversion of 
thio-group to sulfinyl-group increased the antibacterial 
effect against M. luteus. Substitution of nitrofuran by 
nitroimidazole increased the antibacterial effects against B. 
subtilis. Finally, the conversion of the thio-group to 
sulfinyl-group and increasing the length of the hydrocarbon 
chain decreased the antibacterial effects against S. 
pyogenes, which was consistent with the results of a few 
studies (15, 16). The most effective compounds were 2-(5-ni-
tro-2-furyl)-5-(n-buthylthio)-1,3,4-thiadiazole, 2-(5-ni-
tro-2-furyl)-5-(n-penthylthio)-1,3,4-thiadiazole, and 
2-(1-methyl-5-nitro-H1-imidazole-2-yl)-5-(n-butylth-
io)-1,3,4-thiadiazole.
    Due to the dramatic increase in the number of antibiotic-re-
sistant pathogens, the discovery or the synthesis of new 
antimicrobial agents has increased (17). However, there is 
less number of studies about the antibacterial effects of 
nitrofuran and nitroimidazole derivatives of the thiadiazole 
core. Basically, 1,3,4‐thiadiazole has a good activity against 
various microbial strains, and scientists have focused on the 
synthesis of new potent antibacterial and antifungal agents 
by the substitution of different groups (9). Foroumadi et al. 
evaluated the MIC of a series of 2-(1-methyl-5-nitro-2-imi-
dazolyl-1,3,4-thiadiazole-5-alkylsulfides, alkylsulfoxides, 
and alkylsulfones as antitubeculosis agents. They found that 
compounds with a primary alkylthio substitution showed 
good anti-tuberculosis activity (18). In another study, a 
series of 2-(5-nitro-2-furyl)-1,3,4-thiadiazole-2-sulfide, 
sulfoxide, and sulfone compounds were found that had a 
good antituberculosis activity (19). In addition, appropriate 
antibacterial and antifungal properties of the different deriva-
tives of 1,3,4-thiadiazole were reported previously (20-23). 
However, the antibacterial activities of these compounds are 
very low than the routine antibiotics, such as chlorampheni-
col and rifampicin (24). Our findings are also parallel with 
the previous studies about the antibacterial effects of deriva-
tives of 1,3,4-thiadiazole (25, 26). Some studies have also 
reported that certain derivatives of 1,3,4-thiadiazole exhibit-
ed higher antibacterial activity against some bacterial strains 
compared to the standard antibiotics (27). In the study, by 
Serban et al., the results showed that 1,3,4-thiadiazole deriva-
tives are studied more because of their broad spectrum of 
pharmacological activities among the various isomers of 
thiadiazole as well as the substitution at thiadiazole ring for 
obtaining  an improved agent regarding potency and low 
toxicity is challenging (28). Foroumadi et al. revealed that 
the MIC of a series of 2-(1-methyl-5-nitro-2-imida-
zolyl-1,3,4-thiadiazole-5-alkylsulfides, alkylsulfoxides, and 
alkylsulfones reported previously as antifungal agents, were 
determined using the radiometric BACTEC 460-TB method-
ology. They screened active compounds by serial dilutions 
to determine the toxicity in a VERO cell line, and the results 
showed that the compounds with primary alkylthio substitu-
tion had appropriate anti-tuberculosis activity. Moreover, 
oxidation of sulfone attenuated the anti-tuberculosis activity 
of methyl and propyl derivatives (29).
DISCUSSION
IIMMIN 4(2) 1- 8
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